Sean J Yoder Selected Research

Phosphotransferases (Kinase)

1/2016

A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sean J Yoder Research Topics

Disease

20	Neoplasms (Cancer) 01/2024 - 01/2015
3	Melanoma (Melanoma, Malignant) 01/2024 - 01/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 12/2016
3	Adenocarcinoma of Lung 12/2016 - 01/2012
2	Carcinogenesis 01/2023 - 09/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 05/2022
2	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2017
2	Pancreatic Intraductal Neoplasms 09/2015 - 01/2015
2	Large Granular Lymphocytic Leukemia 10/2013 - 11/2003
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024
1	Breast Neoplasms (Breast Cancer) 01/2024
1	Osteosarcoma (Osteogenic Sarcoma) 11/2023
1	Esophageal Neoplasms (Esophageal Cancer) 01/2023
1	Neoplasms, Cystic, Mucinous, and Serous 01/2023
1	Bites and Stings (Sting) 01/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Barrett Esophagus (Barrett's Esophagus) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 04/2018
1	Neurofibrosarcoma (MPNST) 04/2018
1	Ovarian Epithelial Carcinoma 01/2018
1	Adenocarcinoma 01/2017
1	Carcinoma (Carcinomatosis) 09/2015
1	Pancreatic Cyst 01/2015
1	Multiple Myeloma 10/2014
1	Fibrosis (Cirrhosis) 10/2013
1	Cytopenia 10/2013

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2015
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
3	RNA (Ribonucleic Acid)IBA 01/2024 - 05/2022
3	Proteins (Proteins, Gene)FDA Link 10/2018 - 11/2003
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2017
2	NivolumabIBA 01/2022 - 01/2021
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2017 - 01/2016
1	FucoseIBA 01/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2024
1	Interferon Type IIBA 01/2023
1	InterferonsIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	Methionine (L-Methionine)FDA Link 01/2023
1	InflammasomesIBA 01/2023
1	Cetuximab (Erbitux)FDA Link 01/2022
1	Angiopoietin-2IBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	Sirtuin 2IBA 01/2020
1	ParaffinIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Messenger RNA (mRNA)IBA 10/2018
1	Neurofibromin 1 (Neurofibromin)IBA 04/2018
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2018
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Phenformin (Fenformin)IBA 01/2016
1	Peptides (Polypeptides)IBA 10/2014
1	Immunoglobulins (Immunoglobulin)IBA 10/2014
1	CollagenIBA 10/2013
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2013
1	A-Form DNA (A-DNA)IBA 11/2003
1	Amino Acids FDA Link 11/2003

Therapy/Procedure

4	Immunotherapy 01/2024 - 01/2020
4	Therapeutics 11/2023 - 01/2012
2	Drug Therapy (Chemotherapy) 11/2023 - 01/2017
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2023 - 01/2021
1	Cell Transplantation 01/2024
1	Aftercare (After-Treatment) 01/2023
1	Adjuvant Chemotherapy 12/2016